| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $89.6M | +1.5% |
| Cost of Revenue | $24.2M | -2.6% |
| Gross Profit | $65.4M | +3.2% |
| R&D Expense | $23.4M | +10.6% |
| SG&A Expense | $26.9M | -1.8% |
| Operating Income | -$19.0M | +27.7% |
| Pre-tax Income | -$13.6M | +27.0% |
| Income Tax | $98K | +122.7% |
| Net Income | -$13.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.9M | -11.9% |
| Accounts Receivable | $422K | -13.9% |
| Current Assets | $102.3M | -8.6% |
| Total Assets | $132.1M | -9.4% |
| Current Liabilities | $24.4M | -14.3% |
| Total Liabilities | $38.5M | -17.1% |
| Stockholders' Equity | $93.6M | -5.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +16.3% |
| Capital Expenditures | $763K | +23.5% |
| Investing Cash Flow | $5.5M | -75.2% |
| Financing Cash Flow | -$6.4M | +79.2% |
| Free Cash Flow | -$3.2M | +9.3% |
| +26.7% |
| EPS (Basic) | -$0.38 | +22.4% |
| EPS (Diluted) | -$0.38 | +22.4% |